Kangji Medical Holdings Ltd
HKEX:9997
Intrinsic Value
Kangji Medical Holdings Ltd. manufactures invasive surgical instruments and accessories. [ Read More ]
The intrinsic value of one Kangji Medical Holdings Ltd stock under the Base Case scenario is 10.46 HKD. Compared to the current market price of 7.27 HKD, Kangji Medical Holdings Ltd is Undervalued by 30%.
Valuation Backtest
Kangji Medical Holdings Ltd
Run backtest to discover the historical profit from buying and selling Kangji Medical Holdings Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Kangji Medical Holdings Ltd
Current Assets | 3.3B |
Cash & Short-Term Investments | 3B |
Receivables | 169.1m |
Other Current Assets | 134.9m |
Non-Current Assets | 885.8m |
Long-Term Investments | 138.7m |
PP&E | 291.4m |
Intangibles | 451.8m |
Other Non-Current Assets | 3.8m |
Current Liabilities | 363.6m |
Accounts Payable | 29.3m |
Other Current Liabilities | 334.3m |
Non-Current Liabilities | 437.2m |
Long-Term Debt | 41.8m |
Other Non-Current Liabilities | 395.4m |
Earnings Waterfall
Kangji Medical Holdings Ltd
Revenue
|
926m
CNY
|
Cost of Revenue
|
-184.8m
CNY
|
Gross Profit
|
741.2m
CNY
|
Operating Expenses
|
-149.1m
CNY
|
Operating Income
|
592.1m
CNY
|
Other Expenses
|
-88.1m
CNY
|
Net Income
|
504m
CNY
|
Free Cash Flow Analysis
Kangji Medical Holdings Ltd
Profitability Score
Profitability Due Diligence
Kangji Medical Holdings Ltd's profitability score is 77/100. The higher the profitability score, the more profitable the company is.
Score
Kangji Medical Holdings Ltd's profitability score is 77/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Kangji Medical Holdings Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Kangji Medical Holdings Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Kangji Medical Holdings Ltd
According to Wall Street analysts, the average 1-year price target for Kangji Medical Holdings Ltd is 10.25 HKD with a low forecast of 8.99 HKD and a high forecast of 11.76 HKD.
Shareholder Return
Price
Kangji Medical Holdings Ltd
Average Annual Return | -26.3% |
Standard Deviation of Annual Returns | 34.65% |
Max Drawdown | -84% |
Market Capitalization | 8.8B HKD |
Shares Outstanding | 1 214 819 968 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Kangji Medical Holdings Ltd. manufactures invasive surgical instruments and accessories. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2020-06-29. The firm's main products include disposable trocars, polymer ligation clips, disposable electrocoagulation forceps and other disposable products, which are used in gynecology and obstetrics, urology, general surgery and thoracic surgery. The firm distributes its products within the domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Kangji Medical Holdings Ltd stock under the Base Case scenario is 10.46 HKD.
Compared to the current market price of 7.27 HKD, Kangji Medical Holdings Ltd is Undervalued by 30%.